$0.3948
-0.0108-2.66%
Last update: Oct 23, 4:00 PM
Bone Biologics Corp (BBLG) Stock Price, Quote, News & History
BBLGNASDAQ
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.
You can purchase shares of Bone Biologics (NASDAQ:BBLG) through any online brokerage.
Other companies in Bone Biologics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Bone Biologics to provide a consensus price target.
The stock price for Bone Biologics (NASDAQ: BBLG) is $0.3948 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Bone Biologics.
Bone Biologics does not have any upcoming earnings scheduled.
There is no upcoming split for Bone Biologics.
Bone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive...
